Advertisement

Interventions in Structural Heart Diseases: Tricuspid Valve Regurgitation

  • Shingo Kuwata
  • Fabian Nietlispach
  • Francesco Maisano
  • Maurizio Taramasso
Chapter

Abstract

Tricuspid valve disease is mainly represented by tricuspid regurgitation (TR), which is a predictor of poor outcome. Functional (or secondary) TR is the most frequent tricuspid valve disease and correlates with an increased risk of cardiovascular events and death in long-term follow-up. Tricuspid surgery for severe TR should be preferably performed during left valve surgery. When TR persists or worsens following left valvular surgery, redo isolated tricuspid surgery is associated with high mortality. Recently, interest in pathophysiology and management of TR has been growing and new treatment options have been developed. In patients with previous tricuspid surgery, transcatheter valve-in-valve or valve-in-ring procedures can be performed using a transfemoral or transjugular approach. In patients with native disease, many percutaneous techniques mimicking surgical techniques are coming to light and novel transcatheter therapies for the treatment of TR are now emerging. Current experience with these new therapies is preliminary and further studies are needed to determine their role in the management of this clinically relevant disorder.

References

  1. 1.
    Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012;59(8):703–10.CrossRefPubMedGoogle Scholar
  2. 2.
    Kim YJ, Kwon DA, Kim HK, Park JS, Hahn S, Kim KH, Kim KB, Sohn DW, Ahn H, Oh BH, Park YB. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation. 2009;120(17):1672–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Kwon DA, Park JS, Chang HJ, Kim YJ, Sohn DW, Kim KB, Ahn H, Oh BH, Park YB, Choi YS. Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity. Am J Cardiol. 2006;98(5):659–61.CrossRefPubMedGoogle Scholar
  4. 4.
    Staab ME, Nishimura RA, Dearani JA. Isolated tricuspid valve surgery for severe tricuspid regurgitation following prior left heart valve surgery: analysis of outcome in 34 patients. J Heart Valve Dis. 1999;8(5):567–74.PubMedGoogle Scholar
  5. 5.
    Cohen SR, Sell JE, McIntosh CL, Clark RE. Tricuspid regurgitation in patients with acquired, chronic, pure mitral regurgitation. II. Nonoperative management, tricuspid valve annuloplasty, and tricuspid valve replacement. J Thorac Cardiovasc Surg. 1987;94(4):488–97.PubMedGoogle Scholar
  6. 6.
    King RM, Schaff HV, Danielson GK, Gersh BJ, Orszulak TA, Piehler JM, Puga FJ, Pluth JR. Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation. 1984;70(3 Pt 2):I193–7.PubMedGoogle Scholar
  7. 7.
    Matsunaga A, Duran CM. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation. 2005;112(9 Suppl):I453–7.PubMedGoogle Scholar
  8. 8.
    Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Tokuda Y, Matsuo T. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg. 2003;75(6):1826–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M, Kongsaerepong V, Thomas JD, Shiota T. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation. 2005;111(8):975–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Tang GH, David TE, Singh SK, Maganti MD, Armstrong S, Borger MA. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation. 2006;114(1 Suppl):I577–81.PubMedGoogle Scholar
  11. 11.
    Di Mauro M, Bivona A, Iaco AL, Contini M, Gagliardi M, Varone E, Gallina S, Calafiore AM. Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation. Eur J Cardiothorac Surg. 2009;35(4):635–9; discussion 639–40.Google Scholar
  12. 12.
    Sagie A, Schwammenthal E, Palacios IF, King ME, Leavitt M, Freitas N, Weyman AE, Levine RA. Significant tricuspid regurgitation does not resolve after percutaneous balloon mitral valvotomy. J Thorac Cardiovasc Surg. 1994;108(4):727–35.PubMedGoogle Scholar
  13. 13.
    Strier KB. Atelinae adaptations: behavioral strategies and ecological constraints. Am J Phys Anthropol. 1992;88(4):515–24.CrossRefPubMedGoogle Scholar
  14. 14.
    Taramasso M, Maisano F, De Bonis M, Pozzoli A, Schiavi D, Benussi S, Grimaldi A, La Canna G, Alfieri O. Prognostic impact and late evolution of untreated moderate (2/4+) functional tricuspid regurgitation in patients undergoing aortic valve replacement. J Card Surg. 2016;31(1):9–14.CrossRefPubMedGoogle Scholar
  15. 15.
    Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96.CrossRefGoogle Scholar
  16. 16.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice G. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79(1):127–32.CrossRefPubMedGoogle Scholar
  18. 18.
    Hutter A, Bleiziffer S, Richter V, Opitz A, Hettich I, Mazzitelli D, Ruge H, Lange R. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation. Ann Thorac Surg. 2013;95(1):77–84.CrossRefPubMedGoogle Scholar
  19. 19.
    Ohno Y, Attizzani GF, Capodanno D, Cannata S, Dipasqua F, Imme S, Barbanti M, Ministeri M, Caggegi A, Pistritto AM, Chiaranda M, Ronsivalle G, Giaquinta S, Farruggio S, Mangiafico S, Scandura S, Tamburino C, Capranzano P, Grasso C. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip system: 30-day and 12-month follow-up from the GRASP Registry. Eur Heart J Cardiovasc Imaging. 2014;15(11):1246–55.CrossRefPubMedGoogle Scholar
  20. 20.
    Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL, Scientific Document Committee of the European Association of Cardiovascular I. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611–44.CrossRefPubMedGoogle Scholar
  21. 21.
    Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of E. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802.CrossRefPubMedGoogle Scholar
  22. 22.
    Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E, Monin JL, Pierard LA, Badano L, Zamorano JL, European Association of E. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(3):223–44.CrossRefPubMedGoogle Scholar
  23. 23.
    Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713; quiz 786–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Badano LP, Muraru D, Enriquez-Sarano M. Assessment of functional tricuspid regurgitation. Eur Heart J. 2013;34(25):1875–85.CrossRefPubMedGoogle Scholar
  25. 25.
    Rodes-Cabau J, Taramasso M, O’Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet. 2016;388:2431–42.CrossRefPubMedGoogle Scholar
  26. 26.
    Anwar AM, Soliman OI, Nemes A, van Geuns RJ, Geleijnse ML, Ten Cate FJ. Value of assessment of tricuspid annulus: real-time three-dimensional echocardiography and magnetic resonance imaging. Int J Cardiovasc Imaging. 2007;23(6):701–5.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, Bartolles R, Baumann R, Schummers G, Lang RM, Nesser HJ. Multimodality comparison of quantitative volumetric analysis of the right ventricle. JACC Cardiovasc Imaging. 2010;3(1):10–8.CrossRefPubMedGoogle Scholar
  28. 28.
    van der Zwaan HB, Geleijnse ML, McGhie JS, Boersma E, Helbing WA, Meijboom FJ, Roos-Hesselink JW. Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging. Eur J Echocardiogr. 2011;12(9):656–64.CrossRefPubMedGoogle Scholar
  29. 29.
    Ling LF, Marwick TH. Echocardiographic assessment of right ventricular function: how to account for tricuspid regurgitation and pulmonary hypertension. JACC Cardiovasc Imaging. 2012;5(7):747–53.CrossRefPubMedGoogle Scholar
  30. 30.
    Boudjemline Y, Agnoletti G, Bonnet D, Behr L, Borenstein N, Sidi D, Bonhoeffer P. Steps toward the percutaneous replacement of atrioventricular valves an experimental study. J Am Coll Cardiol. 2005;46(2):360–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Figulla HR, Webb JG, Lauten A, Feldman T. The transcatheter valve technology pipeline for treatment of adult valvular heart disease. Eur Heart J. 2016;37(28):2226–39.CrossRefPubMedGoogle Scholar
  32. 32.
    Calvert PA, Himbert D, Brochet E, Radu C, Iung B, Hvass U, Darondel JM, Depoix JP, Nataf P, Vahanian A. Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. EuroIntervention. 2012;7(11):1336–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Hoendermis ES, Douglas YL, van den Heuvel AF. Percutaneous Edwards SAPIEN valve implantation in the tricuspid position: case report and review of literature. EuroIntervention. 2012;8(5):628–33.CrossRefPubMedGoogle Scholar
  34. 34.
    Van Garsse LA, Ter Bekke RM, van Ommen VG. Percutaneous transcatheter valve-in-valve implantation in stenosed tricuspid valve bioprosthesis. Circulation. 2011;123(5):e219–21.CrossRefPubMedGoogle Scholar
  35. 35.
    Roberts P, Spina R, Vallely M, Wilson M, Bailey B, Celermajer DS. Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circ Cardiovasc Interv. 2010;3(4):e14–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Weich H, Janson J, van Wyk J, Herbst P, le Roux P, Doubell A. Transjugular tricuspid valve-in-valve replacement. Circulation. 2011;124(5):e157–60.CrossRefPubMedGoogle Scholar
  37. 37.
    Taramasso M, Nietlispach F, Dvir D, Anabitarte P, Moarof I, Webb JG, Maisano F. Transfemoral tricuspid valve-in-valve implantation: snare it to make it simpler! EuroIntervention. 2016;12(3):402.CrossRefPubMedGoogle Scholar
  38. 38.
    Roberts PA, Boudjemline Y, Cheatham JP, Eicken A, Ewert P, McElhinney DB, Hill SL, Berger F, Khan D, Schranz D, Hess J, Ezekowitz MD, Celermajer D, Zahn E. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol. 2011;58(2):117–22.CrossRefPubMedGoogle Scholar
  39. 39.
    Mazzitelli D, Bleiziffer S, Noebauer C, Ruge H, Mayr P, Opitz A, Tassani-Prell P, Schreiber C, Piazza N, Lange R. Transatrial antegrade approach for double mitral and tricuspid “valve-in-ring” implantation. Ann Thorac Surg. 2013;95(1):e25–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Cabasa AS, Eleid MF, Rihal CS, Villarraga HR, Foley TA, Suri RM. Tricuspid valve replacement: a percutaneous transfemoral valve-in-ring approach. JACC Cardiovasc Interv. 2015;8(8):1126–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Bouleti C, Himbert D, Brochet E, Ou P, Iung B, Nejjari M, Ghodbane W, Fassa AA, Depoix JP, Vahanian A. Transfemoral tricuspid valve-in-ring implantation using the Edwards Sapien XT valve: one-year follow-up. Circ Cardiovasc Interv. 2015;8(3):e002225.CrossRefPubMedGoogle Scholar
  42. 42.
    Mortazavi A, Reul RM, Cannizzaro L, Dougherty KG. Transvenous transcatheter valve-in-valve implantation after bioprosthetic tricuspid valve failure. Tex Heart Inst J. 2014;41(5):507–10.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Condado J, Leonardi R, Babaliaros V. Percutaneous tricuspid valve-in-ring replacement for the treatment of recurrent severe tricuspid regurgitation. Catheter Cardiovasc Interv. 2015;86(7):1294–8.CrossRefPubMedGoogle Scholar
  44. 44.
    McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JD, Goldstein BH, Crittendon I 3rd, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS, Dvir D, Valve-in-Valve International Database R. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation. 2016;133(16):1582–93.CrossRefPubMedGoogle Scholar
  45. 45.
    Taramasso M, Pozzoli A, Guidotti A, Nietlispach F, Inderbitzin DT, Benussi S, Alfieri O, Maisano F. Percutaneous tricuspid valve therapies: the new frontier. Eur Heart J. 2016;38(9):639–47.Google Scholar
  46. 46.
    Schofer J. Transcatheter interventions for tricuspid regurgitation: Trialign and Mitralign. EuroIntervention. 2016;12(Y):Y119–20.CrossRefPubMedGoogle Scholar
  47. 47.
    Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol. 2015;65(12):1190–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Latib A, Agricola E, Pozzoli A, Denti P, Taramasso M, Spagnolo P, Juliard JM, Brochet E, Ou P, Enriquez-Sarano M, Grigioni F, Alfieri O, Vahanian A, Colombo A, Maisano F. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc Interv. 2015;8(13):e211–4.CrossRefPubMedGoogle Scholar
  49. 49.
    Rogers T, Ratnayaka K, Sonmez M, Franson DN, Schenke WH, Mazal JR, Kocaturk O, Chen MY, Faranesh AZ, Lederman RJ. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv. 2015;8(3):483–91.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Rogers JH. Functional tricuspid regurgitation: percutaneous therapies needed. JACC Cardiovasc Interv. 2015;8(3):492–4.CrossRefPubMedGoogle Scholar
  51. 51.
    Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L, Investigators EI. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844–54.CrossRefPubMedGoogle Scholar
  52. 52.
    Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J. 2016;37(10):849–53.CrossRefPubMedGoogle Scholar
  53. 53.
    Schofer J, Tiburtius C, Hammerstingl C, Dickhaut PO, Witt J, Hansen L, Riess FC, Bijuklic K. Transfemoral tricuspid valve repair using a percutaneous mitral valve repair system. J Am Coll Cardiol. 2016;67(7):889–90.CrossRefPubMedGoogle Scholar
  54. 54.
    Wengenmayer T, Zehender M, Bothe W, Bode C, Grundmann S. First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system. EuroIntervention. 2016;11(13):1541–4.CrossRefPubMedGoogle Scholar
  55. 55.
    Braun D, Nabauer M, Massberg S, Hausleiter J. Transcatheter repair of primary tricuspid valve regurgitation using the MitraClip system. JACC Cardiovasc Interv. 2016;9(15):e153–4.CrossRefPubMedGoogle Scholar
  56. 56.
    Sengupta PP, Narula J. Keeping off the wrong track on the right side: planning for transcatheter caval valve implantation. JACC Cardiovasc Imaging. 2015;8(2):232–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Lauten A, Figulla HR, Willich C, Laube A, Rademacher W, Schubert H, Bischoff S, Ferrari M. Percutaneous caval stent valve implantation: investigation of an interventional approach for treatment of tricuspid regurgitation. Eur Heart J. 2010;31(10):1274–81.CrossRefPubMedGoogle Scholar
  58. 58.
    Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, Figulla HR. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 2011;32(10):1207–13.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Lauten A, Hamadanchi A, Doenst T, Figulla HR. Caval valve implantation for treatment of tricuspid regurgitation: post-mortem evaluation after mid-term follow-up. Eur Heart J. 2014;35(25):1651.CrossRefPubMedGoogle Scholar
  60. 60.
    Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv. 2014;7(2):268–72.CrossRefPubMedGoogle Scholar
  61. 61.
    Rodes-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R, Vahanian A. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67(15):1829–45.CrossRefPubMedGoogle Scholar
  62. 62.
    Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol. 2013;61(18):1929–31.CrossRefPubMedGoogle Scholar
  63. 63.
    O’Neill B, Wang DD, Pantelic M, Song T, Guerrero M, Greenbaum A, O’Neill WW. Transcatheter caval valve implantation using multimodality imaging: roles of TEE, CT, and 3D printing. JACC Cardiovasc Imaging. 2015;8(2):221–5.CrossRefPubMedGoogle Scholar
  64. 64.
    O’Neill BP, Wheatley G, Bashir R, Edmundowicz D, O’Murchu B, O’Neill WW, Patil P, Chen A, Forfia P, Cohen HA. Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial. Catheter Cardiovasc Interv. 2016;88(2):287–93.CrossRefPubMedGoogle Scholar
  65. 65.
    Campelo-Parada F, Perlman G, Philippon F, Ye J, Thompson C, Bedard E, Abdul-Jawad Altisent O, Del Trigo M, Leipsic J, Blanke P, Dvir D, Puri R, Webb JG, Rodes-Cabau J. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. J Am Coll Cardiol. 2015;66(22):2475–83.CrossRefPubMedGoogle Scholar
  66. 66.
    Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian A, Messika-Zeitoun D, Baldus S, Huntgeburth M, Alfieri O, Colombo A, La Canna G, Agricola E, Zuber M, Tanner FC, Topilsky Y, Kreidel F, Kuck KH. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J. 2016;37(10):817–25.CrossRefPubMedGoogle Scholar
  67. 67.
    Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL, European Association of E. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307–32.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Shingo Kuwata
    • 1
  • Fabian Nietlispach
    • 1
  • Francesco Maisano
    • 1
  • Maurizio Taramasso
    • 1
    • 2
  1. 1.University Heart Center Zurich, University Hospital of Zurich, University of ZurichZurichSwitzerland
  2. 2.Cardiovascular Surgery DepartmentUniversity Hospital of ZurichZürichSwitzerland

Personalised recommendations